AN AEROSOL COMPOSITION FOR ELIMINATING PATHOGENIC MICROORGANISMS

Abstract

Disclosed herein is a method of eliminating pathogens with an aerosolized composition with polar or charged droplets comprising chlorine dioxide The aerosolized composition is generated from an acidic chlorine dioxide composition comprising at least one charged surfactant.

Claims

1. An aerosol composition of droplets having size of 1 to 120 μm for eliminating pathogenic microorganisms, wherein the droplets are polar and/or charged and said composition is aerosolized from an aqueous composition with a pH of less than 7.5, comprising 10 to 2000 ppm chlorine dioxide (CD); at least one charged surfactant; an acid and optionally other excipients.

2. The composition according to claim 1, wherein the at least one surfactant is a hydrocarbon ionic surfactant selected from cationic surfactants and anionic surfactants.

3. The composition according to claim 2, wherein the hydrocarbon ionic surfactant is selected from at least one of amine oxides, alkyl sulphates, alkyl sulphonates, alkyl aryl sulphonates, aryl sulphonates and salts thereof.

4. The composition according to claim 3, wherein the surfactant is at least one amine oxide, preferably with alkyl groups having 6 to 18 carbon atoms, more preferably the surfactant includes two or more amine oxides with alkyl groups having 6 to 18 carbon atoms, wherein at least two amine oxides have alkyl groups with a difference in hydrocarbon chain length of at least four carbon atoms.

5. The composition according to claim 3, wherein the surfactant is present in amount of less than 2% (v/v), preferably in an amount of 0.1 to 2% (v/v).

6. The composition according to claim 4, wherein the pH is from 1 to 5, the amount of CD is from 100 to 500 ppm and the surfactant is a combination of an amine oxide with 8 carbon atoms and an amine oxide with 12 carbon atoms, preferably the amine oxides are octyl dimethylamine oxide and lauryl dimethylamine oxide.

7. The composition according to claim 1, wherein the pH is from 1.8 to 2.0, the amount of CD is 300 ppm and the surfactant is present in an amount of 0.1 to 0.2% (v/v).

8. The composition according to claim 1, wherein the droplets are electrostatically charged.

9. The composition according to claim 1, wherein the droplets are positively charged.

10. The composition according to claim 1, wherein the droplets have a charge of at least 1 millicoulomb per ml aqueous composition, preferably 1 to 10 millicoulomb per ml aqueous composition.

11. A method of eliminating pathogenic microorganisms comprising: (i) providing an aerosolizable aqueous composition having a pH below 7.5, comprising an effective amount of chlorine dioxide (CD), at least one charged surfactant operable at an acidic pH and in the presence of CD, and optionally one or more suitable excipients; (ii) forming a polar and/or charged aerosol with a droplet size of 1 to 120 μm; and (iii) allowing the aerosol to distribute in a region targeted for pathogen elimination.

12. The method according to claim 11, comprising electrostatically charging the aerosol.

13. The method according to claim 12, wherein the droplets obtain a positive charge, preferably of 1 to 10 millicoulomb per ml aerosolizable composition.

14. The method according to claim 11, wherein the pathogenic microorganism is an airborne pathogen, preferably a respiratory virus.

15. The method according to claim 11, admitting 0.1 ppm CD, or less, in a populated target region.

16. The method according to claim 11, wherein the aerosol comprises 10 to 2000 ppm chlorine dioxide (CD). composition in accordance with any one of claims 1 to 10.

Description

DETAILED AND EXEMPLIFYING DESCRIPTION OF THE INVENTION

Example 1

[0030] LifeClean® (from LifeClean International AB, Uddevalla Sweden) is a commercial chlorine dioxide product with documented surface disinfection effect for a wide range of bacteria, virus and fungi, see https://www.lifeclean.se/media/203776/lifeclean-microbiological-efficacy-summary-20200416.pdf.

[0031] LifeClean® (LC) comprises approximately 300 ppm of chlorine dioxide (CD) in an acidic composition with a pH of about 1.8 and includes a system of the cationic surfactants octyl dimethylamine oxide and lauryl dimethylamine oxide. The surfactant system of LC has been selected so that it remains ionic at the selected, effective pH, is resistant to chlorine dioxide and exhibits complementary wetting and solubilizing effects.

[0032] The present experiments were performed to assess the efficacy of LC to eliminate pathogens in closed potentially contaminated environments in comparison with conventional chlorine dioxide formulations including gaseous chlorine dioxide and thereby assess advantageous embodiments of the invention.

[0033] For this purpose, a bacterial application was performed in the confined space of a 97-liter aquarium. Luminescent bacteria (Aliivibrio fischeri) were obtained with the product LumoStix® and were mixed with buffer according to instructions and placed on absorbent pads for location at predetermined positions in the aquarium. For the following experiments luminescence was measured with a luminometer type Kikkoman PD30. This equipment was provided with a nebulizing spray device type Victory Ecostatic capable of generating both electrostatically positively charged and uncharged aerosols with a particle size of 40 to 110 microns.

[0034] For the experiments, the following agents were tested: [0035] LC is 18 ml LifeClean product distributed on a plate in the aquarium [0036] LCa is LifeClean product applied as non-electrostatic spray/aerosol [0037] LCa+ is LifeClean product applied as electrostatic spray/aerosol [0038] Xa is a pH-neutral pure water solution of approx.300 ppm chlorine dioxide applied as non-electrostatic spray/aerosol [0039] Xa+ is a pH-neutral pure water solution of approx.300 ppm chlorine dioxide applied as electrostatic spray/aerosol.

[0040] In all experiments the luminescence of the bacteria Aliivibrio fischeri was compared to the luminescence immediately before the chlorine dioxide exposure in a relative measurement, using the luminometer. In the first experiments (Study 1-2), the stability of the LumoStix® arrangement including the buffer was studied and the effect was compared to LC alone. The buffer and bacteria were mixed according to the LumoStix® instructions of use and a declination of luminescence was noted. In these tests, the bacteria were exposed to the disinfectant agent (ClO2) after bacteria application on the LumoStix® absorbent pads. In study 1, 18 ml LC was placed in the aquarium on a plate. This setting has resemblance to applying ClO2 gas only to the test object. No aerosol and/or no additional product formulation additives. This corresponds to 10 seconds blow using the spray device producing LCa. The bacteria LumoStix® absorbent pads were exposed to the closed aquarium for 30 seconds. The aim of these studies was to check any possible advantage for further evaluation. In Study 4, LCa was compared to LCa+. The effect on the bacteria was drastic so blow time was reduced to five seconds and incubation of 15 seconds. Study 5 was a copy of Study 4, but the agent is Xa/Xa+ instead of LC/LCa/LCa+

The following experiments were performed:

[0041] Study 1 was an evaluation of if the LumoStix® arrangement was suitable for a LC test and a comparison of LCa versus LC. Study 2 was performed to check stability of the bacteria buffer. Study 3 was a comparison of the performance of LCa versus LC. Study 4 was a comparison of the performance of LCa+ versus LCa. Study 5 was a comparison of the performance Xa versus Xa+.

[0042] The results from Study 1 are presented in Table 1, below, and shows a better effect of 18 ml LCa compared to LC.

[0043] Table 2, below, presents the results form Study 4 and demonstrates the effect on bacterial survival from the exposure of LCa in three different exposures.

[0044] Table 3 below presents the results form Study 4 and demonstrates the effect on bacterial survival from the exposure of LCa+ in three different exposures. It is evident comparing Table 2 and 3, that LCa+ is more efficient in eliminating bacterial in the present test model than LCa.

[0045] Tables 4 and 5, below presents the results from Study 5 and demonstrate the effect of Xa and Xa+, respectively. In comparison with the results of Tables 1 and 3, it is evident that LCa and LCa+ is more efficacious than Xa/Xa+ in in the present test model.

[0046] In conclusion, from Studies (1-2) it was found that the buffer needs to be room temperate (approximately 1 hour) and measurements should be performed approximately 3 minutes after any exposure of chlorine dioxide. It was also shown that LCa has a more pronounced effect than LC, see Table 1. The bacteria were suitably sensitive for chlorine dioxide and LumoStix® is accordingly a suitable system for the following studies 3-5.

[0047] From the Tables 2-5, showing Studies 3-5, it can be concluded that LCa is more effective compared to LC during the time period in the experiment (Study 3). In Study 4, LCa+ was 1,7-1,8 more effective than LCa. This effect could not be noted in Study 5, comparing Xa versus Xa+ without the additives of LifeClean®.

[0048] It is shown that the survival fraction, measured as a reduction of bacteria light emission, was higher using LCa compered to LC. The effect was enhanced by electrostatic charging of LC, i.e., generating LCa+. The effect on electrostatic charging could not be shown using pure ClO2 (Xa+). It was also noted that the luminescence further declined in the tests with LCa and LCa+, but not LC and Xa/Xa+

[0049] In summary the methods and the aerosol compositions according to the present invention, based on a chlorine dioxide composition comprising at least one charged surface-active component, have an improved efficacy in eliminating microorganisms.

TABLE-US-00001 TABLE 1 Study 1 LCa LC Survival fraction 48% 72% 18% 67% 62% 85% Mean 43% 75%

TABLE-US-00002 TABLE 2 LCa 1 2 3 Start 1200 223 274 Min 1 1078 — Min 2 1138 241 Min 3 1105 252 Mean 1130 239 After exposure 108 84 95 +15 sek 62 84 +15 sek 38 81 Survival fraction 9.6% 35% 34% Mean 26%

TABLE-US-00003 TABLE 3 LCa+ Start 968 227 264 Min 1 717 239 Min 2 639 — 241 Min 3 651 235 240 Mean 743 233 248 After exposure 39 42 51 +15 sek 16 26 36 +15 sek 11 39 Survival fraction   20% Mean 5.2% 18% 14.4%

TABLE-US-00004 TABLE 4 Xa Start 484 232 210 Min 1 453 236 201 Min 2 417 232 193 Min 3 440 164 192 Mean 448 216 199 233 After exposure 148 109 75 +15 sek 150 111 — +15 sek 148 110 74 Survival fraction 33% 48 37% Mean 39%

TABLE-US-00005 TABLE 5 Xa+ Start 288 200 344 Min 1 277 233 321 Min 2 265 — 308 Min 3 259 218 302 Mean 272 217 318 After exposure 91 113 97 +15 sek 91 106 — +15 sek 90 108 93 Survival fraction 33% 52% 30% Mean 38%

Example 2

[0050] This example demonstrates the efficacy of the methods and composition of the invention to eliminate pathogens in a targeted space represented by the interior of an emergency vehicle.

[0051] E Coli K12 (1.5 cm culture, Heraco) were suspended in NaCl and grafted to agar plates comprising horse blood with a conventional needle in of 10 μm in 3 rounds and conventionally distributed in zig-zag patterns, while rotating the agar plate ⅓ . The so prepared agar plates acclimatized for an hour and incubated 24 hours. 4 plates were kept as control and 7 were placed in different parts in the compartment of the emergency vehicle.

[0052] LifeClean® (LC) comprising approximately 300 ppm of chlorine dioxide was introduced in the 8 m.sup.3 volume of the emergency vehicle compartment with the nebulizer Victory Ecostatic of Example 1 with a 40 micron nozzle providing 3.4 oz/min or 97 ml LC per minute. The nebulizer was operated for 1 minute 6 times between breaks of 30 seconds, followed by 3 minutes exposure giving a total exposure time of 11-12 minutes. The estimated theoretically maximum concentration of gaseous chlorine dioxide in the compartment was about 20 ppm. In practice, chlorine dioxide will present both as gas and dissolved in the aerosol droplets during the exposure.

[0053] After exposure were both control plates and exposed plates aerated before incubation and CFU (colony forming unit) count to avoid chlorine dioxide to affect control.

[0054] The results after CFU count are demonstrated in Table 6. All control plates had a CFU of>400.

TABLE-US-00006 TABLE 6 Location in vehicle of plate CFU Count 1. Front seat right  15 2. Shelf above driver  23 3. Rear stretcher  40 4. Right upper cabinet  6 5. Left upper cabinet  28 6. Right shelf medium height  2 7. Front stretcher   100+

[0055] Even if agar plate 7 is an outlier, the results of Table 6 show that the method and composition according to the invention has clear efficacy in sanitary procedure in eliminating pathogens in potentially infected emergency vehicle. The results indicate that 92 to 95% elimination is reached. Accordingly, the invention will be useful in effectively eliminating a wide range of pathogens in a surprisingly fast an expedient way and will be useful in many clinical and public settings where airborne pathogens are expected to contaminate closed spaces and rooms.